Product overview
Type
Diphtheria-Tetanus-Pertussis (acellular)
Commercial Name
Boostrix
Manufacturer
GlaxoSmithKline Biologicals SA
URL
Responsible NRA
Federal Agency for Medicines and Health Products
Country
Belgium
Prequalification
Prequalification Status
Current
Product description
Pharmaceutical Form
Liquid: ready to use
Presentation
Vial
Number of Doses
1
Diluent
Not Applicable
Route of Administration
Intramuscular
Shelf Life
48 months
Storage Temperature
2-8°C
Vaccine Vial Monitor
Type 30
Secondary Packaging
Carton of 10 vials [Dimension 8.8 x 3.7 x 4.2 cm]
Tertiary Packaging
Box of 135 cartons of 10 vials (1850 vials/1850 doses) [Dimension of 33.2 x 24.1 x 41.0 cm]
Multidose Vial Policy
Not Applicable.
Vaccine Preservative
none
Cold Chain Volume
13.7 cm3/dose (in secondary packaging)